Putnam Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $519M | Buy |
3,350,980
+178,111
| +6% | +$26M | 0.69% | 49 |
|
|
2023
Q3 | $473M | Buy |
3,172,869
+438,442
| +16% | +$64.4M | 0.72% | 45 |
|
|
2023
Q2 | $368M | Sell |
2,734,427
-116,131
| -4% | -$17M | 0.54% | 67 |
|
|
2023
Q1 | $454M | Sell |
2,850,558
-318,712
| -10% | -$48.7M | 0.73% | 47 |
|
|
2022
Q4 | $512M | Buy |
3,169,270
+67,712
| +2% | +$10.4M | 0.89% | 33 |
|
|
2022
Q3 | $416M | Sell |
3,101,558
-364,224
| -11% | -$52.3M | 0.79% | 34 |
|
|
2022
Q2 | $531M | Sell |
3,465,782
-2,464,149
| -42% | -$377M | 0.95% | 25 |
|
|
2022
Q1 | $961M | Buy |
5,929,931
+147,991
| +3% | +$21.5M | 1.45% | 9 |
|
|
2021
Q4 | $783M | Buy |
5,781,940
+10,696
| +0.2% | +$1.26M | 1.12% | 16 |
|
|
2021
Q3 | $623M | Buy |
5,771,244
+5,833
| +0.1% | +$667K | 0.97% | 21 |
|
|
2021
Q2 | $649M | Buy |
5,765,411
+731,262
| +15% | +$82.4M | 1.01% | 21 |
|
|
2021
Q1 | $545M | Buy |
5,034,149
+102,885
| +2% | +$11M | 0.91% | 25 |
|
|
2020
Q4 | $528M | Sell |
4,931,264
-4,477
| -0.1% | -$430K | 0.94% | 25 |
|
|
2020
Q3 | $432M | Buy |
4,935,741
+147,122
| +3% | +$13.9M | 0.85% | 31 |
|
|
2020
Q2 | $470M | Buy |
4,788,619
+332,028
| +7% | +$29.2M | 1% | 24 |
|
|
2020
Q1 | $340M | Buy |
4,456,591
+95,840
| +2% | +$8.16M | 0.89% | 24 |
|
|
2019
Q4 | $386M | Buy |
4,360,751
+38,143
| +0.9% | +$3.17M | 0.8% | 25 |
|
|
2019
Q3 | $327M | Buy |
4,322,608
+687,740
| +19% | +$47.2M | 0.73% | 30 |
|
|
2019
Q2 | $264M | Buy |
3,634,868
+2,953,331
| +433% | +$232M | 0.59% | 45 |
|
|
2019
Q1 | $54.9M | Buy |
681,537
+342,477
| +101% | +$28M | 0.13% | 157 |
|
|
2018
Q4 | $31.3M | Buy |
339,060
+36,495
| +12% | +$3.21M | 0.08% | 188 |
|
|
2018
Q3 | $28.6M | Sell |
302,565
-1,504
| -0.5% | -$143K | 0.06% | 221 |
|
|
2018
Q2 | $28.2M | Sell |
304,069
-502,064
| -62% | -$49M | 0.06% | 213 |
|
|
2018
Q1 | $76.3M | Sell |
806,133
-404,513
| -33% | -$44.4M | 0.18% | 133 |
|
|
2017
Q4 | $117M | Buy |
1,210,646
+1,174,799
| +3,277% | +$111M | 0.26% | 107 |
|
|
2017
Q3 | $3.19M | Sell |
35,847
-1,471
| -4% | -$112K | 0.01% | 630 |
|
|
2017
Q2 | $2.71M | Sell |
37,318
-6,444
| -15% | -$433K | 0.01% | 695 |
|
|
2017
Q1 | $2.85M | Sell |
43,762
-2,867
| -6% | -$180K | 0.01% | 779 |
|
|
2016
Q4 | $2.92M | Sell |
46,629
-1,437
| -3% | -$87.7K | 0.01% | 749 |
|
|
2016
Q3 | $3.03M | Sell |
48,066
-782,233
| -94% | -$50.6M | 0.01% | 723 |
|
|
2016
Q2 | $51.4M | Sell |
830,299
-145,322
| -15% | -$8.85M | 0.13% | 175 |
|
|
2016
Q1 | $55.7M | Sell |
975,621
-880,774
| -47% | -$49.1M | 0.13% | 164 |
|
|
2015
Q4 | $110M | Buy |
1,856,395
+157,446
| +9% | +$9.07M | 0.25% | 90 |
|
|
2015
Q3 | $92.4M | Sell |
1,698,949
-400,859
| -19% | -$26.1M | 0.21% | 115 |
|
|
2015
Q2 | $141M | Sell |
2,099,808
-316,476
| -13% | -$20.7M | 0.28% | 75 |
|
|
2015
Q1 | $141M | Sell |
2,416,284
-1,271,221
| -34% | -$76.8M | 0.28% | 78 |
|
|
2014
Q4 | $241M | Buy |
3,687,505
+41,558
| +1% | +$2.62M | 0.5% | 37 |
|
|
2014
Q3 | $211M | Sell |
3,645,947
-402,999
| -10% | -$22.4M | 0.45% | 52 |
|
|
2014
Q2 | $229M | Buy |
4,048,946
+150,385
| +4% | +$7.89M | 0.49% | 48 |
|
|
2014
Q1 | $200M | Buy |
3,898,561
+961,082
| +33% | +$48.6M | 0.45% | 60 |
|
|
2013
Q4 | $155M | Sell |
2,937,479
-418,037
| -12% | -$20.5M | 0.37% | 68 |
|
|
2013
Q3 | $150M | Buy |
3,355,516
+156,837
| +5% | +$6.95M | 0.4% | 65 |
|
|
2013
Q2 | $132M | Buy |
+3,198,679
| New | +$140M | 0.39% | 63 |
|
Other funds holding ABBV
Putnam Investments's ABBV Position: Q4 2023 in Review
Putnam Investments increased its AbbVie (ABBV) stake by 5.6% in Q4 2023, buying an estimated $26M and bringing the position to 3,350,980 shares worth $519M. The position accounts for 0.69% of the portfolio, ranked #49.
Putnam Investments first reported a position in ABBV in Q2 2013 and has held it in 43 quarters since. The position peaked at $961M in Q1 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.
- Putnam Investments held 3,350,980 shares of AbbVie worth $519M as of Q4 2023.
- Putnam Investments bought 178,111 AbbVie shares in Q4 2023, an estimated $26M.
- AbbVie made up 0.69% of Putnam Investments's portfolio in Q4 2023, its #49 holding.
- Putnam Investments first reported a position in AbbVie in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's AbbVie position peaked at $961M in Q1 2022.
- 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.